These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Targeted systemic radiotherapy with scVEGF/177Lu leads to sustained disruption of the tumor vasculature and intratumoral apoptosis. Blankenberg FG; Levashova Z; Goris MG; Hamby CV; Backer MV; Backer JM J Nucl Med; 2011 Oct; 52(10):1630-7. PubMed ID: 21890879 [TBL] [Abstract][Full Text] [Related]
4. Imaging VEGF Receptors and α Tekabe Y; Li Q; Zhang G; Johnson J; Schmidt AM; Backer M; Backer J; Johnson LL Mol Imaging Biol; 2018 Dec; 20(6):963-972. PubMed ID: 29687324 [TBL] [Abstract][Full Text] [Related]
5. Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants. Meyer JP; Edwards KJ; Kozlowski P; Backer MV; Backer JM; Lewis JS J Nucl Med; 2016 Nov; 57(11):1811-1816. PubMed ID: 27390161 [TBL] [Abstract][Full Text] [Related]
6. Selective Imaging of Vascular Endothelial Growth Factor Receptor-1 and Receptor-2 in Atherosclerotic Lesions in Diabetic and Non-diabetic ApoE Tekabe Y; Johnson LL; Rodriquez K; Li Q; Backer M; Backer JM Mol Imaging Biol; 2018 Feb; 20(1):85-93. PubMed ID: 28421362 [TBL] [Abstract][Full Text] [Related]
7. Noninvasive assessment of tumor VEGF receptors in response to treatment with pazopanib: a molecular imaging study. Blankenberg FG; Levashova Z; Sarkar SK; Pizzonia J; Backer MV; Backer JM Transl Oncol; 2010 Feb; 3(1):56-64. PubMed ID: 20165696 [TBL] [Abstract][Full Text] [Related]
8. ScVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA conjugates: comparison of easy-to-label recombinant proteins for [68Ga]PET imaging of VEGF receptors in angiogenic vasculature. Eder M; Krivoshein AV; Backer M; Backer JM; Haberkorn U; Eisenhut M Nucl Med Biol; 2010 May; 37(4):405-12. PubMed ID: 20447550 [TBL] [Abstract][Full Text] [Related]
9. SU11248, a selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cells. Young E; Miele L; Tucker KB; Huang M; Wells J; Gu JW Cancer Biol Ther; 2010 Oct; 10(7):703-11. PubMed ID: 20686367 [TBL] [Abstract][Full Text] [Related]
10. Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors. Castillo-Avila W; Piulats JM; Garcia Del Muro X; Vidal A; Condom E; Casanovas O; Mora J; Germà JR; Capellà G; Villanueva A; Viñals F Clin Cancer Res; 2009 May; 15(10):3384-95. PubMed ID: 19417025 [TBL] [Abstract][Full Text] [Related]
11. Monitoring therapeutic efficacy of sunitinib using [(18)F]FDG and [(18)F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinoma. Thézé B; Bernards N; Beynel A; Bouet S; Kuhnast B; Buvat I; Tavitian B; Boisgard R BMC Cancer; 2015 Jul; 15():534. PubMed ID: 26198000 [TBL] [Abstract][Full Text] [Related]
12. A new PET tracer specific for vascular endothelial growth factor receptor 2. Wang H; Cai W; Chen K; Li ZB; Kashefi A; He L; Chen X Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2001-10. PubMed ID: 17694307 [TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines. Fukasawa M; Korc M Clin Cancer Res; 2004 May; 10(10):3327-32. PubMed ID: 15161686 [TBL] [Abstract][Full Text] [Related]
15. Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype. Piao Y; Liang J; Holmes L; Zurita AJ; Henry V; Heymach JV; de Groot JF Neuro Oncol; 2012 Nov; 14(11):1379-92. PubMed ID: 22965162 [TBL] [Abstract][Full Text] [Related]
16. Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma. Huang D; Ding Y; Li Y; Luo WM; Zhang ZF; Snider J; Vandenbeldt K; Qian CN; Teh BT Cancer Res; 2010 Feb; 70(3):1053-62. PubMed ID: 20103629 [TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447 [TBL] [Abstract][Full Text] [Related]
18. The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma. Wu Y; Hooper AT; Zhong Z; Witte L; Bohlen P; Rafii S; Hicklin DJ Int J Cancer; 2006 Oct; 119(7):1519-29. PubMed ID: 16671089 [TBL] [Abstract][Full Text] [Related]
19. Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model. Yokoi K; Thaker PH; Yazici S; Rebhun RR; Nam DH; He J; Kim SJ; Abbruzzese JL; Hamilton SR; Fidler IJ Cancer Res; 2005 May; 65(9):3716-25. PubMed ID: 15867367 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor associated with tumor cell proliferation in canine cutaneous squamous cell carcinomas and trichoepitheliomas. Al-Dissi AN; Haines DM; Singh B; Kidney BA Vet Pathol; 2007 Nov; 44(6):823-30. PubMed ID: 18039895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]